Compounds > beta-alanine

beta-alanine and az 505

beta-alanine has been researched along with az 505 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, H; Cheung, T; Cowen, S; Ferguson, AD; Garcia-Arenas, R; Godin, R; Grande, C; Green, I; Howard, T; Keen, N; Larsen, NA; Pollard, H; Wu, J1
Calvet, JP; Fan, LX; Grantham, JJ; Li, LX; Li, X; Sage, J; Zhou, JX1
Calvet, JP; Godwin, AK; Jensen, RA; Li, LX; Li, X; Zhou, JX1
Bayliss, G; Guan, Y; Li, X; Liu, F; Liu, L; Xiong, C; Zhang, C; Zhao, TC; Zhuang, S; Zou, J1

Other Studies

4 other study(ies) available for beta-alanine and az 505

ArticleYear
Structural basis of substrate methylation and inhibition of SMYD2.
    Structure (London, England : 1993), 2011, Sep-07, Volume: 19, Issue:9

    Topics: Amino Acid Motifs; Antineoplastic Agents; Benzoxazines; beta-Alanine; Binding Sites; Catalytic Domain; Coenzymes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Enzyme Assays; Esophageal Neoplasms; High-Throughput Screening Assays; Histone-Lysine N-Methyltransferase; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Methylation; Models, Molecular; Peptide Fragments; Protein Binding; Surface Properties; Tumor Suppressor Protein p53

2011
Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
    The Journal of clinical investigation, 2017, Jun-30, Volume: 127, Issue:7

    Topics: Animals; Benzoxazines; beta-Alanine; Cell Proliferation; Cysts; Epigenesis, Genetic; Epithelial Cells; Histone-Lysine N-Methyltransferase; MAP Kinase Signaling System; Methylation; Mice; Mice, Mutant Strains; Polycystic Kidney, Autosomal Dominant; Protein Kinase C; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor; TOR Serine-Threonine Kinases; Transcription Factor RelA; TRPP Cation Channels

2017
Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.
    Cell death & disease, 2018, 02-27, Volume: 9, Issue:3

    Topics: Animals; Apoptosis; Benzoxazines; beta-Alanine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytokines; Disease Progression; DNA Methylation; Feedback, Physiological; HEK293 Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Mice, Nude; Models, Biological; Phosphorylation; Protein Binding; Signal Transduction; STAT3 Transcription Factor; Transcription Factor RelA; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018
Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:7

    Topics: Animals; Benzoxazines; beta-Alanine; Cell Proliferation; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibroblasts; Fibrosis; Histone-Lysine N-Methyltransferase; Kidney; Kidney Diseases; Lysine; Male; Methyltransferases; Mice; Mice, Inbred C57BL; Phosphorylation; Rats; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Ureteral Obstruction

2021